Pathways’ Picks November 18: Diagnostics Developments and More

article image

In this week’s roundup: Diagnostic policy updates from Europe and the US, including an important EU IVDR guideline and pandemic news. Also: FDA pressured on establishing OTC hearing aids and MedTech Europe entered a “value” alliance.

The past week has been packed with diagnostics policy developments, which is where we start this edition of Pathways Picks, including a long-awaited EU IVDR guidance, a noteworthy COVID-19 EUA, and the latest CPT coding news.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: